In vitro and in vivo characterization of a novel CCR3 antagonist, YM-344031

This publication has 36 references indexed in Scilit:

• Anti–interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes☆
  Journal of Allergy and Clinical Immunology, 2004
• Functional Expression and Characterization of Macaque C-C Chemokine Receptor 3 (CCR3) and Generation of Potent Antagonistic Anti-macaque CCR3 Monoclonal Antibodies
  Published by Elsevier ,2002
• Identification of Potent, Selective Non-peptide CC Chemokine Receptor-3 Antagonist That Inhibits Eotaxin-, Eotaxin-2-, and Monocyte Chemotactic Protein-4-induced Eosinophil Migration
  Published by Elsevier ,2000
• A Small Molecule Antagonist of Chemokine Receptors CCR1 and CCR3
  Published by Elsevier ,2000
• Tryptase-Chymase Double-Positive Human Mast Cells Express the Eotaxin Receptor CCR3 and Are Attracted by CCR3-Binding Chemokines
  The American Journal of Pathology, 1999
• Eotaxin-2, a Novel CC Chemokine that Is Selective for the Chemokine Receptor CCR3, and Acts Like Eotaxin on Human Eosinophil and Basophil Leukocytes
  The Journal of Experimental Medicine, 1997
• Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia
  The Journal of Experimental Medicine, 1997
• Molecular Cloning and Functional Expression of a New Human CC-Chemokine Receptor Gene
  Biochemistry, 1996
• Eotaxin: Cloning of an Eosinophil Chemoattractant Cytokine and Increased mRNA Expression in Allergen-Challenged Guinea-Pig Lungs
  Biochemical and Biophysical Research Communications, 1994
• Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation.
  The Journal of Experimental Medicine, 1994